Patents by Inventor Gerald D. Shockman

Gerald D. Shockman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies to peptidoglycan and methods of preparing same
    Patent number: 4596769
    Abstract: Several novel hybridoma cell lines, ATCC #HB-8510, 8511, 8512, 8513, 8514, 8515, 8516, and 8517 produce monoclonal antibody to an antigen, peptidoglycan, which is a normal structural component of neREFERENCE TO GOVERNMENTThe invention described herein was supported by National Institutes of Health grants DE-03487 and DE-05160.
    Type: Grant
    Filed: March 5, 1984
    Date of Patent: June 24, 1986
    Assignee: Temple University
    Inventors: Gerald D. Shockman, Dianne E. Jackson, William Wong
  • Group B Streptococcus antigens and vaccines
    Patent number: 4439422
    Abstract: Pure Group B Streptococcus antigen and Group B, Type III Streptococcus antigen are isolated, separated and purified from the culture medium in which the Group B, Type III Streptococcus are grown. The process involves (a) culturing the Group B, Type III Streptococcus in a nutrient medium, free of animal proteins and lipids, containing from 1 to 5% by weight glucose and from 0.04 M to 0.16 M phosphates; (b) separating the bacterial cells from the culture medium; (c) extracting and separating the Group B antigens and the Type III antigens from the culture medium supernatant by means of an anion exchanger; and, (d) purifying the resulting antigenic materials by chromatography on an agarose gel column. The antigens can be used as vaccines against infections caused by Group B or Group B, Type III Streptococcus.
    Type: Grant
    Filed: February 2, 1982
    Date of Patent: March 27, 1984
    Assignee: Research Corporation
    Inventors: Robert M. Swenson, Gerald D. Shockman, Toby K. Eisenstein, Roberta B. Carey